What is the address of DR.BARBARA VERMEIREN?

The registered office of DR.BARBARA VERMEIREN is located at Opwijksestraat 171, 9280 Lebbeke.

Is DR.BARBARA VERMEIREN still active?

Yes. According to the CBE (29 October 2026) DR.BARBARA VERMEIREN is active, legal situation “Normale toestand”, started on 8 March 2005.

Is DR.BARBARA VERMEIREN registered on Peppol?

No, DR.BARBARA VERMEIREN is currently not registered on the Peppol network.

What is the enterprise number of DR.BARBARA VERMEIREN?

The enterprise number of DR.BARBARA VERMEIREN is BE0872340004.

When was DR.BARBARA VERMEIREN founded?

DR.BARBARA VERMEIREN was founded on 8 March 2005.

Who are the directors of DR.BARBARA VERMEIREN?

According to the 2025 annual accounts, the directors of DR.BARBARA VERMEIREN are: Thomas Rose, Barbara Vermeiren.

Is DR.BARBARA VERMEIREN a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 8 March 2005; 4 annual accounts filed, latest fiscal year 2025; 2 directors known from the annual account.

How much profit did DR.BARBARA VERMEIREN make in 2025?

DR.BARBARA VERMEIREN posted a profit after taxes of € 244,510 in financial year 2025.

What is the revenue of DR.BARBARA VERMEIREN?

As a small company, DR.BARBARA VERMEIREN is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € 410,656.

How many employees does DR.BARBARA VERMEIREN have?

According to the 2025 annual accounts, DR.BARBARA VERMEIREN has 0 full-time equivalents (FTE).

DR.BARBARA VERMEIREN (Private Limited) - Lebbeke

Dossier DR.BARBARA VERMEIREN, printed on 29 October 2026 from databakkes.be/en/0872340004/dr-barbara-vermeiren. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Warning lights

Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.

Not on Peppol Peppol

Not registered in the Peppol network, mandatory for VAT-liable companies since 1 January 2026.

Financials

Financial year 2025

DR.BARBARA VERMEIREN from Lebbeke, company number BE0872340004, closed financial year 2025 with a result of € 244,510 after tax. For that financial year DR.BARBARA VERMEIREN recorded a gross margin of € 410,656 and equity of € 1.7 million. Compared with financial year 2024, the result moved from € 131,904 to € 244,510. Profitable, and profit is growing. The buffer is growing. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on October 30, 2025.

What it is worth Growing

€ 1.7 million

▲ 14% vs 2024

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit Growing

€ 244,510

▲ 85% vs 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 269,005

▲ 127% vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Pays out

€ 32,129 paid out

13 % of the profit went to the shareholders, the rest stayed in the company.

People and assets in 2025

Full-time equivalents

Average over the fiscal year, from the social balance sheet.

Vehicles and equipment

€ 39,229

▼ 17% vs 2024

Book value of vehicles, furniture and equipment.

Debts at end 2025

Bank debt ≈ 6 years to go The accounts give the long-term loan and the part due within the year. The remainder divided by that part is the number of years at an equal pace; a new loan or early repayment changes it.

€ 155,183

▼ 15% vs 2024

€ 28,012 is repaid this year. At this pace the long-term loan is gone in ≈ 6 years.

Owed to suppliers

€ 38

▼ 99% vs 2024

Supplier invoices still open on the last day of the fiscal year.

Taxes and wages

€ 44,159

▲ 241% vs 2024

Taxes, VAT and social contributions still to pay.

Key figures per fiscal year Download key figures (CSV)
	2022	2023	2024	2025	Change 2024 → 2025
Gross margin	€ 254,008 Gross margin 2022: € 254,008 First fiscal year in the series	€ 203,417 Gross margin 2023: € 203,417 ▼ 20% vs 2022 (€ 254,008) Unfavourable step	€ 231,673 Gross margin 2024: € 231,673 ▲ 14% vs 2023 (€ 203,417) Favourable step	€ 410,656 Gross margin 2025: € 410,656 ▲ 77% vs 2024 (€ 231,673) Favourable step	▲ 77%
Profit after taxes	€ 158,199 Profit after taxes 2022: € 158,199 First fiscal year in the series	€ 117,899 Profit after taxes 2023: € 117,899 ▼ 25% vs 2022 (€ 158,199) Unfavourable step	€ 131,904 Profit after taxes 2024: € 131,904 ▲ 12% vs 2023 (€ 117,899) Favourable step	€ 244,510 Profit after taxes 2025: € 244,510 ▲ 85% vs 2024 (€ 131,904) Favourable step	▲ 85%
Equity	€ 1,343,250 Equity 2022: € 1,343,250 First fiscal year in the series	€ 1,429,020 Equity 2023: € 1,429,020 ▲ 6% vs 2022 (€ 1,343,250) Favourable step	€ 1,518,066 Equity 2024: € 1,518,066 ▲ 6% vs 2023 (€ 1,429,020) Favourable step	€ 1,730,448 Equity 2025: € 1,730,448 ▲ 14% vs 2024 (€ 1,518,066) Favourable step	▲ 14%
Total debts	€ 254,435 Total debts 2022: € 254,435 First fiscal year in the series	€ 224,863 Total debts 2023: € 224,863 ▼ 12% vs 2022 (€ 254,435) Favourable step	€ 204,229 Total debts 2024: € 204,229 ▼ 9% vs 2023 (€ 224,863) Favourable step	€ 200,687 Total debts 2025: € 200,687 ▼ 2% vs 2024 (€ 204,229) Favourable step	▼ 2%
Cash	€ 101,180 Cash 2022: € 101,180 First fiscal year in the series	€ 142,001 Cash 2023: € 142,001 ▲ 40% vs 2022 (€ 101,180) Favourable step	€ 118,537 Cash 2024: € 118,537 ▼ 17% vs 2023 (€ 142,001) Unfavourable step	€ 269,005 Cash 2025: € 269,005 ▲ 127% vs 2024 (€ 118,537) Favourable step	▲ 127%
Land & buildings	€ 364,665 Land & buildings 2022: € 364,665 First fiscal year in the series	€ 347,256 Land & buildings 2023: € 347,256 ▼ 5% vs 2022 (€ 364,665) Unchanged	€ 321,410 Land & buildings 2024: € 321,410 ▼ 7% vs 2023 (€ 347,256) Unchanged	€ 288,907 Land & buildings 2025: € 288,907 ▼ 10% vs 2024 (€ 321,410) Unchanged	▼ 10%
Retained profit	€ 1,330,850 Retained profit 2022: € 1,330,850 First fiscal year in the series	€ 1,416,620 Retained profit 2023: € 1,416,620 ▲ 6% vs 2022 (€ 1,330,850) Favourable step	€ 1,505,666 Retained profit 2024: € 1,505,666 ▲ 6% vs 2023 (€ 1,416,620) Favourable step	€ 1,718,048 Retained profit 2025: € 1,718,048 ▲ 14% vs 2024 (€ 1,505,666) Favourable step	▲ 14%
Dividend	€ 64,258 Dividend 2022: € 64,258 First fiscal year in the series	€ 32,129 Dividend 2023: € 32,129 ▼ 50% vs 2022 (€ 64,258) Unchanged	€ 42,857 Dividend 2024: € 42,857 ▲ 33% vs 2023 (€ 32,129) Unchanged	€ 32,129 Dividend 2025: € 32,129 ▼ 25% vs 2024 (€ 42,857) Unchanged	▼ 25%
Bank debt	€ 237,535 Bank debt 2022: € 237,535 First fiscal year in the series	€ 210,362 Bank debt 2023: € 210,362 ▼ 11% vs 2022 (€ 237,535) Favourable step	€ 182,913 Bank debt 2024: € 182,913 ▼ 13% vs 2023 (€ 210,362) Favourable step	€ 155,183 Bank debt 2025: € 155,183 ▼ 15% vs 2024 (€ 182,913) Favourable step	▼ 15%
Balance sheet total	€ 1,597,685 Balance sheet total 2022: € 1,597,685 First fiscal year in the series	€ 1,653,883 Balance sheet total 2023: € 1,653,883 ▲ 4% vs 2022 (€ 1,597,685) Unchanged	€ 1,722,296 Balance sheet total 2024: € 1,722,296 ▲ 4% vs 2023 (€ 1,653,883) Unchanged	€ 1,931,135 Balance sheet total 2025: € 1,931,135 ▲ 12% vs 2024 (€ 1,722,296) Unchanged	▲ 12%

Key figures of DR.BARBARA VERMEIREN, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 October 2026.

What happened to DR.BARBARA VERMEIREN?

What happened at DR.BARBARA VERMEIREN in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

Oct 30, 2025 New annual accounts for financial year 2025: profit of € 244,510 (▲ 85% vs 2024). Source: NBB ↗
Feb 25, 2008 New establishment in Lebbeke. KBO
Mar 8, 2005 Start of the company according to the CBE. KBO

In short

From € 158,199 profit in 2022 to € 244,510 profit in 2025.

Paid € 276,107 in corporate taxes since 2022.

Best year ever: 2025, with € 244,510 profit.

Paid out € 171,373 in dividends to the owners in total.

Original PDFs at the National Bank ↗

Management

Thomas Rose

Barbara Vermeiren

DR.BARBARA VERMEIREN

Medische Beeldvorming Dender-monde 100%

Behind DR.BARBARA VERMEIREN are Thomas Rose and Barbara Vermeiren. It owns 100% of Medische Beeldvorming Dender-monde itself.

Directors

According to the 2025 annual accounts

Thomas Rose

Director

Also active at: Stichting Brandwonden - Fondation des brûlés, Medische Beeldvorming Dendermonde, Belgian Burnsurvivors Association

Barbara Vermeiren

Director

Also active at: GUNEI, Medische Beeldvorming Dendermonde

Establishments

Establishment units

Physical locations of this company

Registered office

Opwijksestraat 171

9280 Lebbeke

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Details

Company number: 0872.340.004
VAT number: BE 0872.340.004
Registered office: Opwijksestraat 171, 9280 Lebbeke
Names & denominations: DR.BARBARA VERMEIREN
Enterprise type: Rechtspersoon
Legal form: Private limited company
Legal situation: Normale toestand
Start date: 8 March 2005
Peppol: Not registered
Contact: [email protected] 0477609243

View on CBE Public ↗ Annual accounts (NBB) ↗